Skip to main content

Advertisement

Log in

Therapeutic Outcome and Prognostic Factors of Invasive Aspergillosis in an Infectious Disease Department: A Review of 34 Cases

  • Clinical and Epidemiological Study
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Background:

Invasive aspergillosis (IA) is one of the most frequent, feared and life-threatening opportunistic infection in immunocompromised patients. We wished to assess the therapeutic outcome and identify prognostic factors of IA.

Methods:

We reviewed retrospectively all patients managed in our department for a proven or probable IA over the last 10 years.

Results:

A total of 34 patients were identified: 20 hematopoietic stem cell recipients, 7 infected with the human immunodeficiency virus, 6 hematological malignancies, and only 1 diabetes mellitus. IA involved the lower respiratory tract in all but one case with sinonasal infection. Among patients with pulmonary IA, sinuses were involved in four cases and the brain in five cases. First line antifungal therapy included amphotericin B deoxycholate (56%) or its lipid formulations (18%), itraconazole (15%) and voriconazole (12%). Eight patients also underwent surgery. Median survival was only 64 days and 73% of patients died during follow-up. A favorable outcome of IA was documented in only 48% of patients. Multivariate analysis identified neutropenia as the only factor associated with unsuccessful outcome (p = 0.003).

Conclusions:

IA remains therefore associated with a highmortality rate, especially in patients with neutropenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mert A, Ozaras R, Tabak F, Bilir M, Yilmaz M, Kurt C, Ongoren S, Tanriverdi M, Ozturk R: The sensitivity and specificity of Brucella agglutination tests. Diagn Microbiol Infect Dis 2003; 46: 241–243.

    Article  PubMed  Google Scholar 

  2. Turkish Ministry of Health Statistics. http://www.saglik.gov.tr/extras/istatistikler/ger_bil_2001/t_32.htm.

  3. Mantur BG, Mangalgi SS, Mulimani B: Brucella melitensis — a sexually transmissible agent. Lancet 1996; 347: 1763.

    Article  PubMed  CAS  Google Scholar 

  4. Young EJ: Brucella species. In: Mandell GL, Bennett JE, Dolin R (eds) Mandel, Douglas and Bennett’s principles and practice of infectious diseases. 5th edition Churchill-Livingstone, Philadelphia 2000, pp 2386–2393.

    Google Scholar 

  5. Fosgate GT, Carpenter TE, Chomel BB, et al. Time-space clustering of human brucellosis, California, 1973–1992. Emerg Infect 2002; 8: 672–678.

    Google Scholar 

  6. Wide RI: Brucellosis in the United States: past, present, and future. JAMA 1980; 224: 2318–2322.

    Google Scholar 

  7. Alsubaie S, Almuneef M, Alshaalan M, et al. Acute brucellosis in Saudi families: relationship between brucella serology and clinical symptoms. Int J Infect Dis 2005; 9: 218–224.

    Article  PubMed  Google Scholar 

  8. Gotuzzo E, Carrillo C, Seas C, et al. Epidemiological and clinical features of brucellosis in a 39 family groups. Enferm Infecc Microbiol Clin 1989; 7: 519–524.

    PubMed  CAS  Google Scholar 

  9. Abramson O, Rosenvasser Z, Block C, Dagan R: Detection and treatment of brucellosis by screening a population at risk. Pediatr Infect Dis J 1991; 10: 434–438.

    Article  PubMed  CAS  Google Scholar 

  10. Cetinkaya F, Nacar M, Aydin T: Prevalence of brucellosis in the rural area of Kayseri, Central Anatolia, Turkey. Int J Infect Dis 2006; 10: 179–181.

    Article  PubMed  Google Scholar 

  11. Almuneef M, Memish ZA, Balkhy HH, et al. Importance of screening household members of acute brucellosis cases in endemic areas. Epidemiol Infect 2004; 132: 533–540.

    Article  PubMed  CAS  Google Scholar 

  12. Gur A, Geyik FM, Dikici B, et al. Complications of brucellosis in different age groups: a study of 283 cases in Southeastern Anatolia of Turkey. Yonsei Med J 2003; 44: 33–44.

    PubMed  Google Scholar 

  13. Ozturk R, Mert A, Kocak F, et al. The diagnosis of brucellosis by use of BACTEC 9240 blood culture system. Diagn Microbiol Infect Dis 2002; 44: 133–135.

    Article  PubMed  CAS  Google Scholar 

  14. Yagupsky P, Peled N, Press J, et al. Rapid detection of Brucella melitensis from blood cultures by a commercial system. Eur J Clin Microbiol Infect Dis 1997; 16: 605–607.

    Article  PubMed  CAS  Google Scholar 

  15. Bannatyne R, Jackson M, Memish Z: Rapid diagnosis of Brucella bacteremia by using the BACTEC 9240 system. J Clin Microbiol 1997; 35: 2673–2674.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Gallien.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gallien, S., Fournier, S., Porcher, R. et al. Therapeutic Outcome and Prognostic Factors of Invasive Aspergillosis in an Infectious Disease Department: A Review of 34 Cases. Infection 36, 533–538 (2008). https://doi.org/10.1007/s15010-008-7375-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-008-7375-x

Keywords

Navigation